NCT05261984

Brief Summary

ICU survivors often suffer from long-term functional disability. An attenuated response to physical exercise in skeletal muscle after critical illness may contribute to persisting weakness. The aim of this study is to investigate the effects of resistance exercise on muscle protein synthesis in former ICU patients. The investigators hypothesize that study subjects recovering from critical illness have an impaired anabolic response to resistance exercise after ICU stay as compared to non-critically ill controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
6 days until next milestone

Study Start

First participant enrolled

March 8, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2024

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

1.9 years

First QC Date

February 20, 2022

Last Update Submit

February 16, 2024

Conditions

Keywords

Resistance exerciseMuscle proteinAnabolic resistance

Outcome Measures

Primary Outcomes (1)

  • Muscle protein fractional synthetic rate

    The difference between the experimental and active comparator group in muscle protein fractional synthetic rate.

    150 minutes post-exercise.

Secondary Outcomes (2)

  • Gene expression

    150 minutes post-exercise.

  • Signaling pathways

    150 minutes post-exercise.

Study Arms (2)

Former ICU patients

EXPERIMENTAL

Research subjects with a prior history of ICU treatment within six months.

Procedure: Resistance exerciseDietary Supplement: Oral protein supplementation

Age- and sex-matched control group

ACTIVE COMPARATOR

Research subjects without a prior history of ICU treatment within the last 30 years, age- and sex-matched in a 1:2 ratio to the experimental arm.

Procedure: Resistance exerciseDietary Supplement: Oral protein supplementation

Interventions

Knee extensions in flywheel inertia machine in four sets of 10 repetitions.

Age- and sex-matched control groupFormer ICU patients

24 grams of hydrolyzed whey protein.

Age- and sex-matched control groupFormer ICU patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (≥18 years) previously admitted to an ICU at Karolinska University Hospital for ≥3 days and discharged alive from hospital
  • Adult (≥18 years) without a history of ICU admission (control group)

You may not qualify if:

  • Not able to provide informed consent
  • \>6 months since ICU discharge\*
  • Warfarin or dual antiplatelet therapy
  • Clinically significant inherited or acquired disorder of hemostasis
  • Lower-limb amputee
  • Lower-limb atherosclerotic disease with critical ischemia.
  • Recent fracture in lower limbs or significant osteoarthritis limiting movement in knee or hip joint
  • Metastatic cancer or active hematological malignancy
  • Inherited disorder of amino acid metabolism.
  • Chronic muscle, neuromuscular or neurologic disease with prior documentation of clinically significant lower-limb involvement
  • Pregnancy
  • Single organ failure not requiring invasive mechanical ventilation during ICU stay\*
  • Intubated only for airway protection with no other organ failure(s) during ICU stay\*
  • Planned postoperative care in ICU after elective cardiothoracic surgery\*

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Huddinge, Stockholm County, 14186, Sweden

Location

Related Publications (9)

  • Batt J, Herridge MS, Dos Santos CC. From skeletal muscle weakness to functional outcomes following critical illness: a translational biology perspective. Thorax. 2019 Nov;74(11):1091-1098. doi: 10.1136/thoraxjnl-2016-208312. Epub 2019 Aug 20.

    PMID: 31431489BACKGROUND
  • Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM; Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011 Apr 7;364(14):1293-304. doi: 10.1056/NEJMoa1011802.

    PMID: 21470008BACKGROUND
  • Plank LD, Connolly AB, Hill GL. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg. 1998 Aug;228(2):146-58. doi: 10.1097/00000658-199808000-00002.

    PMID: 9712558BACKGROUND
  • Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, Hopkinson NS, Phadke R, Dew T, Sidhu PS, Velloso C, Seymour J, Agley CC, Selby A, Limb M, Edwards LM, Smith K, Rowlerson A, Rennie MJ, Moxham J, Harridge SD, Hart N, Montgomery HE. Acute skeletal muscle wasting in critical illness. JAMA. 2013 Oct 16;310(15):1591-600. doi: 10.1001/jama.2013.278481.

    PMID: 24108501BACKGROUND
  • Wolfe RR. Skeletal muscle protein metabolism and resistance exercise. J Nutr. 2006 Feb;136(2):525S-528S. doi: 10.1093/jn/136.2.525S.

    PMID: 16424140BACKGROUND
  • Doiron KA, Hoffmann TC, Beller EM. Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit. Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD010754. doi: 10.1002/14651858.CD010754.pub2.

    PMID: 29582429BACKGROUND
  • Connolly B, Salisbury L, O'Neill B, Geneen L, Douiri A, Grocott MP, Hart N, Walsh TS, Blackwood B; ERACIP Group. Exercise rehabilitation following intensive care unit discharge for recovery from critical illness. Cochrane Database Syst Rev. 2015 Jun 22;2015(6):CD008632. doi: 10.1002/14651858.CD008632.pub2.

    PMID: 26098746BACKGROUND
  • Fossat G, Baudin F, Courtes L, Bobet S, Dupont A, Bretagnol A, Benzekri-Lefevre D, Kamel T, Muller G, Bercault N, Barbier F, Runge I, Nay MA, Skarzynski M, Mathonnet A, Boulain T. Effect of In-Bed Leg Cycling and Electrical Stimulation of the Quadriceps on Global Muscle Strength in Critically Ill Adults: A Randomized Clinical Trial. JAMA. 2018 Jul 24;320(4):368-378. doi: 10.1001/jama.2018.9592.

    PMID: 30043066BACKGROUND
  • Hickmann CE, Castanares-Zapatero D, Deldicque L, Van den Bergh P, Caty G, Robert A, Roeseler J, Francaux M, Laterre PF. Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial. Crit Care Med. 2018 Sep;46(9):1436-1443. doi: 10.1097/CCM.0000000000003263.

    PMID: 29957714BACKGROUND

MeSH Terms

Conditions

Critical IllnessMuscular Atrophy

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalSigns and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Martin Sundström Rehal, MD PhD

    Karolinska University Hospital

    PRINCIPAL INVESTIGATOR
  • Olav Rooyackers, PhD

    Karolinska University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 20, 2022

First Posted

March 2, 2022

Study Start

March 8, 2022

Primary Completion

January 18, 2024

Study Completion

January 18, 2024

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations